fibroblast activation protein (FAP) | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

21,416 results for “fibroblast activation protein (FAP)”

Trials

View all 12107 →

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

70 participants · First posted Jan 5, 2024

Not yet recruiting

Correlation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid Arthritis and Systemic Sclerosis)

111 participants · First posted Feb 6, 2026

18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis

20 participants · First posted Apr 22, 2025

Drugs

View all 1695 →

Fibroblast Activation Protein(Umoja Biopharma)

68Ga-DOTA-FAPI

3B-201

Organizations

View all 78 →

Protein Sciences Corporation

United States

HOUSE OF SUPPLEMENTS AUSTRALIA PTY LTD

Australia

Werewolf Therapeutics

United States

News

View all 7536 →

Avacta to Present Updated Phase 1a Data for FAP-Targeted Doxorubicin Conjugate AVA6000 at ESMO 2025

Oncomatryx Secures €25 Million to Advance OMTX705 Clinical Trials in Metastatic Solid Tumors

Precirix Receives FDA Clearance to Begin Phase 1 Trial of CAM-FAP-Ac-225 Targeted Alpha Therapy

Page 1 of 2142